文献速递中医内科中药与中成药合理使用

防己与含人参中药复方NSENL逆转肺癌顺铂耐药

Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts.
PubMed 文献 · Am J Chin Med · 2017-02-23

本研究评估新复方NSENL(含防己、人参等)对顺铂耐药人肺癌A549/DDP裸鼠移植瘤的逆转作用。HPLC定量6种成分,NSENL联合DDP抑瘤率达66.8%,并下调MRP1、bFGF、FGFR1等耐药相关基因及蛋白,抑制PI3K/Akt/mTOR通路。

要点

  • NSENL联合顺铂显著抑制A549/DDP移植瘤生长,抑瘤率66.8%。
  • NSENL下调MRP1、bFGF、FGFR1的mRNA和蛋白表达。
  • NSENL降低GST-π蛋白、肿瘤微血管密度及Akt/mTOR磷酸化。

核心结论

  • NSENL可在体内逆转A549/DDP细胞的多药耐药,机制可能与下调耐药相关基因及抑制bFGF/FGFR和PI3K/Akt/mTOR信号通路有关。

研究设计与样本

  • 采用HPLC定量NSENL中6种成分,建立A549/DDP细胞裸鼠移植瘤模型评估NSENL抗肿瘤效果及对MDR相关基因表达的影响。

主要发现

  • NSENL联合DDP对肿瘤生长的抑制率最高达66.8%。
  • NSENL单用或联合DDP在mRNA和蛋白水平下调MRP1、bFGF和FGFR1。
  • NSENL降低GST-π蛋白表达和肿瘤微血管密度,并减少Akt和mTOR磷酸化。

关键数值与推荐

  • NSENL中定量了人参皂苷Rg1、Rb1、Rg3、黄芪甲苷IV、麦冬皂苷D和汉防己碱共6种成分。

临床怎么用

  • 提示含防己与人参的复方NSENL可能作为顺铂耐药肺癌的辅助治疗策略,但需临床研究验证。

局限性

  • 研究仅基于裸鼠移植瘤模型,尚未在人体中验证NSENL的安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chinese Herbal Formulation, supplement energy and nourish lung (SENL), effectively enhances chemotherapeutic efficacy in lung cancer treatment and reverses multi-drug resistance (MDR) in lung cancer cells in vitro. The present study is designed to assess the effect of a New SENL (NSENL, modification of SENL) formulation on resistance to chemotherapy of cisplatin (DDP)-resistant human lung cancer cell line (A549/DDP) xenografts in nude mice. We assessed six constituents in NSENL by high performance liquid chromatography (HPLC). BALB/c nude mice harboring A549/DDP cell xenografts were established to assess the antitumor effect of NSENL and its impact on the expression of MDR related genes. The six constituents in NSENL, including ginsenoside Rg1, ginsenoside Rb1, ginsenoside Rg3, astragaloside IV, ophiopogonin D and tetrandrine were quantitated simultaneously by HPLC. The combination of NSENL with DDP significantly inhibited tumor growth at a rate of up to 66.8% ([Formula: see text]). In addition, NSENL as monotherapy or combined with DDP downregulated multidrug resistance-associated protein 1 (MRP1), basic fibroblast growth factor (bFGF) and fibroblast growth factor receptor 1 (FGFR1) at both the mRNA and protein levels ([Formula: see text]), reduced glutathione S-transferase π (GST-π) protein expression and tumor microvascular density as well as decreased phosphorylation of protein kinase B (Akt) and mammalian target of rapamycin (mTOR) ([Formula: see text]). These findings demonstrated that NSENL can reverse MDR in A549/DDP cells in vivo, an effect possibly associated with downregulation of MDR-associated genes as well as inhibition of bFGF/FGFR and phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR signaling pathways.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Jin L, Xu M, Luo XH, et al. Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts. Am J Chin Med. 2017. PMID: 28231742. doi:10.1142/S0192415X17500240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。